When the Dept of Human Services notices multiple Rx/prescribers, who must they inform?

The Department of Human Services is required to inform the medical director of the opioid treatment program when they notice multiple prescriptions from various prescribers. This requirement is rooted in the need for coordinated care and monitoring within programs that handle opioid addiction treatments. The medical director oversees treatment protocols and patient management strategies, making them an essential contact for ensuring that patients receiving opioid treatment are not engaging in risky behaviors, such as "doctor shopping."

Informing the medical director allows for proper assessment and intervention if necessary, which helps maintain the integrity of the treatment program and addresses potential cases of misuse or abuse of controlled substances. This communication is critical in safeguarding patient care and enhancing public health initiatives directed at managing the opioid crisis.

The other options might not be as effective in addressing the specific concerns of overlapping prescriptions and the need for immediate action in an opioid treatment context. While responsibilities may exist with the hospital administrator, pharmacy board, or the individual prescriber, the role of the medical director is particularly crucial in the context of an opioid treatment program.